Search Results - drug

5 Results Sort By:
Antisense Therapeutic Agents for Treatment of Covid-19
Technology Description This technology licensing opportunity relates to antisense agent compounds for treating or preventing a SARS-CoV-2 infection. A key feature of this technology is unique cell penetrating peptide and antisense oligomer (CPP-PMO) combinations that provide improved antiviral efficacy and reduced cytotoxicity. The compounds are oligomers...
Published: 9/9/2020   |   Inventor(s): David Stein, Hong Moulton, Kyle Rosenke, Heinrich Feldmann
Keywords(s): antisense, coronavirus, covid-19, Drug, SARS-CoV-2, Therapeutic
Category(s): Therapeutics
Peptide Inhibitors of Gonorrhoeae
Technology Description Antigonococcal peptide inhibitors of Neisseria gonorrhoeae that act against a non-conventional new target, nitrite reductase AniA, that is necessary for N. gonorrhoeae anaerobic respiration and biofilm formation. The anaerobic life style is an important state during disease and favored in biofilms, which form in cervical gonococcal...
Published: 6/8/2017   |   Inventor(s): Aleksandra Sikora, Konstantin Korotkov
Keywords(s): Antibiotics, Antimicrobial, Drug, Drug Development, Gonorrhea, Inhibitor, Microbiology, Peptide, Therapeutic
Category(s): Therapeutics, Vaccines
New Antifungal Analogs
Technology Description This technology licensing opportunity provides biosynthetic methods for the production of the antidiabetic drug voglibose. Briefly, antifungal validamycin A analogs, including 1,1′-bis-valienamine, are produced using valN mutant strains of Streptomyces organisms, such as Streptomyces hygroscopicus. The 1,1′-bis-valienamine...
Published: 5/20/2016   |   Inventor(s): Taifo Mahmud, Hui Xu, Jongtae Yang, Zixin Deng, Linquan Bai
Keywords(s): Agriculture, Biomedical, Drug, drugs, Medical Science & Technologies, pharmaceuticals
Category(s): Therapeutics, Agricultural
New Approach for Treatment of Type I Diabetes
Technology Description This licensing and collaborative research opportunity relates to a new approach to treating diabetes mellitus type 1 (T1DM). The patent pending methods of treatment focus on the use of compounds that provide suppression of autoimmune responses that lead to destruction of pancreatic beta cells. The possibility of preventing disease...
Published: 5/13/2016   |   Inventor(s): Nancy Kerkvliet, Siva Kolluri
Keywords(s): Diabetes, Drug, Immune, Therapeutic
Category(s): Chemical, Therapeutics
Lymphatic drug delivery system and drugs for metastatic melanoma
Technology Description Oregon State University is seeking a licensee for a patented drug delivery system for the treatment of metastatic melanoma. The system is composed of biodegradable, biocompatible, and stable nanoparticles built from amphiphilic block copolymers and contains a mix of drugs commonly used to treat cancer, all while being nontoxic...
Published: 11/23/2015   |   Inventor(s): Adam Alani
Keywords(s): Cancer, Drug, Drug Delivery, drugs, lymphatic, melanoma, metastatic tumor, pharmaceuticals, Therapeutic
Category(s): Therapeutics
© 2021. All Rights Reserved. Powered by Inteum